Middle East & Africa Predictive Biomarkers Market Size & Outlook

The predictive biomarkers market in Middle East & Africa is expected to reach a projected revenue of US$ 1,982.0 million by 2030. A compound annual growth rate of 18.9% is expected of Middle East & Africa predictive biomarkers market from 2025 to 2030.
Revenue, 2024 (US$M)
$723.6
Forecast, 2030 (US$M)
$1,982.0
CAGR, 2025 - 2030
18.9%
Report Coverage
Middle East & Africa

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Middle East & Africa predictive biomarkers market, 2018-2030 (US$M)

Middle East & Africa predictive biomarkers market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

MEA predictive biomarkers market highlights

  • The MEA predictive biomarkers market generated a revenue of USD 723.6 million in 2024.
  • The market is expected to grow at a CAGR of 18.9% from 2025 to 2030.
  • In terms of segment, cancer was the largest revenue generating indication in 2024.
  • Cardiovascular Diseases is the most lucrative indication segment registering the fastest growth during the forecast period.
  • Country-wise, UAE is expected to register the highest CAGR from 2025 to 2030.


MEA data book summary

Market revenue in 2024USD 723.6 million
Market revenue in 2030USD 1,982.0 million
Growth rate18.9% (CAGR from 2025 to 2030)
Largest segmentCancer
Fastest growing segmentCardiovascular Diseases
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases, Other


Other key industry trends

  • In terms of revenue, MEA region accounted for 3.0% of the global predictive biomarkers market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 15,309.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Predictive Biomarkers Market Companies

Name Profile # Employees HQ Website
PacBio View profile 501-1000 Menlo Park, California, United States, North America https://www.pacb.com
Genomic Health View profile 501-1000 Redwood City, California, United States, North America http://www.genomichealth.com
F. Hoffmann-La Roche Ltd. View profile - - -
PerkinElmer View profile 10001+ Waltham, Massachusetts, United States, North America http://www.perkinelmer.com
Bio-Techne Corp View profile 3050 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 https://www.bio-techne.com
Myriad Genetics Inc View profile 2700 320 Wakara Way, Salt Lake City, UT, United States, 84108 https://www.myriad.com
Qiagen NV View profile 5900 Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL https://www.qiagen.com
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
Illumina Inc View profile 9300 5200 Illumina Way, San Diego, CA, United States, 92122 https://www.illumina.com
Danaher Corp View profile 63000 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 https://www.danaher.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com
Becton Dickinson & Co View profile 73000 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 https://www.bd.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com

Middle East & Africa predictive biomarkers market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to predictive biomarkers market will help companies and investors design strategic landscapes.


Cancer was the largest segment with a revenue share of 42.59% in 2024. Horizon Databook has segmented the Middle East & Africa predictive biomarkers market based on cancer, cardiovascular diseases, neurological diseases, immunological diseases, other covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Middle East & Africa predictive biomarkers market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Middle East & Africa predictive biomarkers market databook

  • Our clientele includes a mix of predictive biomarkers market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa predictive biomarkers market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa predictive biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

MEA predictive biomarkers market size, by country, 2018-2030 (US$M)

Middle East & Africa Predictive Biomarkers Market Outlook Share, 2024 & 2030 (US$M)

MEA predictive biomarkers market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online